Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00513526
What this trial is testing

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Who this might be right for
InfectionPrecancerous Condition
AIDS Malignancy Consortium 112
Large-scale testing (Phase 3)Study completedNCT01967940
What this trial is testing

Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults

Who this might be right for
HIVHIV InfectionsAcquired Immunodeficiency Syndrome
Gilead Sciences 55
Large-scale testing (Phase 3)UnknownNCT02902185
What this trial is testing

Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir

Who this might be right for
Chronic HIV Infections
Tang-Du Hospital 60
Early research (Phase 1)UnknownNCT04620291
What this trial is testing

Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation in HIV Infected Adults

Who this might be right for
HIV-1-infection
United BioPharma 18
Large-scale testing (Phase 3)Study completedNCT00046176
What this trial is testing

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 240
Early research (Phase 1)Study completedNCT03204617
What this trial is testing

Safety and Immunogenicity Study of DNA.HTI, MVA.HTI and ChAdOx1.HTI in HIV-1-positive Patients (AELIX-002)

Who this might be right for
HIV
Aelix Therapeutics 45
Large-scale testing (Phase 3)Study completedNCT01709084
What this trial is testing

A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment

Who this might be right for
Human Immunodeficiency Virus-type 1 Infection
Janssen-Cilag International NV 426
Large-scale testing (Phase 3)Active Not RecruitingNCT04776252
What this trial is testing

Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 2,000
Large-scale testing (Phase 3)Study completedNCT03547908
What this trial is testing

Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults

Who this might be right for
HIV-1/HBV Co-Infection
Gilead Sciences 244
Not applicableStudy completedNCT00002443
What this trial is testing

The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 780
Not applicableActive Not RecruitingNCT06358885
What this trial is testing

IGHID 12230 - An Implementation Trial of an Experiential Brief Alcohol Intervention for HIV Prevention

Who this might be right for
HIV-1-infectionUnhealthy Alcohol Use
University of North Carolina, Chapel Hill 3,234
Large-scale testing (Phase 3)Active Not RecruitingNCT06333808
What this trial is testing

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

Who this might be right for
HIV-1-infection
Gilead Sciences 577
Not applicableStudy completedNCT03508908
What this trial is testing

Tambua Mapema Plus - to Discover HIV Infection Early and Prevent Onward Transmission

Who this might be right for
HIV Infections
University of Oxford 2,887
Not applicableStudy completedNCT04718974
What this trial is testing

Call for Life Youth ART Adherence Study

Who this might be right for
ART AdherenceHIV-1-infectionmHealth
Makerere University 206
Testing effectiveness (Phase 2)Study completedNCT01295515
What this trial is testing

Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 7
Early research (Phase 1)Study completedNCT03212989
What this trial is testing

Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)

Who this might be right for
HIV-1 Infection
University of North Carolina, Chapel Hill 17
Large-scale testing (Phase 3)Study completedNCT04223778
What this trial is testing

Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 672
Early research (Phase 1)Study completedNCT01140126
What this trial is testing

Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults

Who this might be right for
HIV-1 Infection in Adults (Asymptomatic)
United Biomedical 20
Post-approval studies (Phase 4)Study completedNCT00724711
What this trial is testing

Safety and Efficacy Study of Switching From Epzicom to Truvada

Who this might be right for
HIV Infection
Gilead Sciences 312
Not applicableStudy completedNCT00006298
What this trial is testing

Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 125
Next Page